---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-057488"
form_type: "8-K"
ticker: "LPAA"
cik: "0002015502"
company_name: "Launch One Acquisition Corp."
filed_at: "2025-06-25T23:59:59+00:00"
generated_at: "2026-05-18T21:31:30.187451+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Launch One Acquisition Corp. to combine with Minovia Therapeutics at $180M valuation, targeting Q4 2025 close

## Summary
- Minovia pre-money valuation of $180M; equity holders eligible for up to $57.5M earnout based on milestones.
- Launch One trust holds ~$239.7M cash; at least $18M in PIPE investments and $5M bridge financing expected.
- Lead product MNV-201 has FDA Fast Track and Rare Pediatric Disease designations; pivotal trial in preparation.
- Transaction unanimously approved by both boards; expected to close Q4 2025 subject to shareholder approvals.
- Combined company to be named Mito US One Ltd. and list on Nasdaq under new ticker.

## SEC filing metadata
- accession: 0001213900-25-057488
- form_type: 8-K
- ticker: LPAA
- cik: 0002015502
- company_name: Launch One Acquisition Corp.
- filed_at: 2025-06-25T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2015502/000121390025057488/0001213900-25-057488-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2015502/000121390025057488/ea0246872-8k425_launch.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-057488
- JSON: https://secwatch.observer/filing/0001213900-25-057488.json
- Plain text: https://secwatch.observer/filing/0001213900-25-057488.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.